News

Analyst Insights: DA Davidson Adjusts Braze Inc Price Target

Analyst Insights: DA Davidson Adjusts Braze Inc Price Target

DA Davidson Adjusts Price Target for Braze Inc

Braze Inc (NASDAQ: BRZE), a prominent player in customer engagement, has recently seen its price target updated by DA Davidson. The new target is now set at $55.00, down from the previous $65.00. Despite this decrease, DA Davidson continues to recommend a Buy rating on the stock. This adjustment follows Braze's investor day held on Monday, where the company shared vital information about its financial strategies and current customer trends in light of ongoing economic pressures.

Insights from Braze's Management During Investor Day

During the investor day presentation, Braze's management team discussed the company's growth outlook with an emphasis on the Dollar-Based Net Retention (DBNR) rate. This crucial metric, which tracks customer spending over time, was reported to be around 110% by the end of the second fiscal quarter of 2024—a slight drop from last year's rate of 114%.

Analysis of Growth Trajectory and Key Financial Metrics

The management also shared a scenario analysis aimed at achieving the "rule of 40" status within the next four years. This important benchmark in the software industry requires that a company's combined growth rate and profit margin exceed 40%, highlighting a balance between profitability and expansion. This focus on long-term sustainable growth strategies demonstrates strong managerial intentions to guide Braze towards a successful future.

DA Davidson's Reasoning for the Price Target Adjustment

Even though the price target has been adjusted, DA Davidson has reaffirmed its Buy rating for Braze Inc. The new target reflects a multiple of 7x the company's revised revenue expectations for the fiscal year 2026. This recalibration takes into account insights from the investor day as well as the ongoing macroeconomic challenges impacting the industry.

Revenue Growth and Expansion of the Customer Base

Braze Inc. reported an impressive 26% increase in revenue during the fiscal second quarter of 2025, amounting to $145.5 million. The company also successfully welcomed 61 new customers, increasing its total to 2,163 clients. This consistent expansion can be attributed to the successful rollout of the Braze data platform, which has significantly enhanced customer engagement and retention.

Analyst Outlook and Future Expectations

The overall market sentiment regarding Braze is optimistic, with analysts from TD Cowen and other firms reiterating a Buy position. They anticipate that the company's dollar-based net retention will stabilize, which should lead to a normalization of performance metrics in the next few months. For the upcoming third quarter, revenue is expected to be between $147.5 million and $148.5 million, while projections for the entire fiscal year 2025 place revenue between $582.5 million and $585.5 million.

Braze ended the quarter with a non-GAAP operating income of $4.2 million, accounting for 3% of its revenue, and boasts cash and cash equivalents of $504 million. This solid liquidity profile is crucial, as it highlights the company's stability during these challenging economic times.

Insights from InvestingPro

In light of the recent changes along with DA Davidson’s price target update for Braze Inc (NASDAQ: BRZE), InvestingPro offers valuable insights into the company’s financial condition. Braze has a market capitalization of $3.56 billion, showcasing its strong position within the customer engagement sector. Despite facing specific challenges, the company maintains a solid liquidity profile that exceeds its debt obligations, which is essential for financial stability.

Stock Volatility and Analyst Forecasts

InvestingPro notes that Braze's stock has experienced notable volatility, trading near its 52-week low over the past six months. Nevertheless, there have been positive developments, with 11 analysts raising their earnings forecasts for the near future, indicating potential optimism about the company’s ability to navigate current difficulties. Additionally, the company’s liquid assets remain greater than its short-term liabilities, reflecting a healthy financial standing. Analysts express confidence that Braze could achieve profitability this year.

Frequently Asked Questions

What is the new price target for Braze Inc?

The new price target for Braze Inc set by DA Davidson is $55.00, down from the previous target of $65.00.

What is the Dollar-Based Net Retention rate for Braze Inc?

As of the end of the second fiscal quarter of 2024, Braze Inc's DBNR rate stood at approximately 110%.

How has Braze Inc performed in revenue recently?

Braze Inc reported a 26% increase in fiscal second quarter 2025 revenue, reaching $145.5 million with the addition of 61 new customers.

What are analysts predicting for Braze's future revenue?

Analysts project Braze's revenue for the third quarter to fall between $147.5 million and $148.5 million, with the full fiscal year revenue expected to be between $582.5 million and $585.5 million.

What is the current sentiment towards Braze Inc from analysts?

The market sentiment towards Braze Inc remains positive, with several analysts maintaining a Buy rating, anticipating stability in the company’s performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 8

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

Bonerge Launches Groundbreaking Clinical Trial for Skin Health

Updated Category News Views 268

Bonerge's New Clinical Trial Focuses on Anti-Aging Innovations Bonerge has launched an ambitious clinical trial that includes 108 participants aiming to explore the benefits of three powerful antioxidants: Fisetin, Urolithin A, and Ergothioneine. This trial is set to evaluate the effects of these ingredients on skin health and their potential to rejuvenate organs, marking...

Continue Reading
Understanding the Dynamics of First Solar's Options Market

Updated Category News Views 137

Analyzing First Solar's Options Market Activity In recent weeks, First Solar (NASDAQ: FSLR) has seen a surge in bullish activity among investors, a trend that market watchers find intriguing. This uptick in options trading is not just a random occurrence; it suggests that significant movements are anticipated in the near future. Our analysis of public options data...

Continue Reading
Headway Partners with National Quality Forum to Innovate Behavioral Health Assessment

Updated Category News Views 98

Transforming Behavioral Health Assessments for Better Care Headway, a leader in mental healthcare innovation, has taken a significant step by becoming the first launch partner of the Aligned Innovation initiative, spearheaded by the National Quality Forum (NQF). This initiative focuses on the need for enhanced healthcare quality measures, particularly in the realm of...

Continue Reading
Trends in Options Trading for Airbnb You Should Know

Updated Category News Views 222

Understanding the Current Options Trading Landscape for Airbnb Recently, there has been a notable shift in the options trading environment for Airbnb. Large investors, often referred to as whales, are embracing a bullish outlook on the company. This sentiment is reflected in the trading behaviors observed in the market. Delving into the options activity for Airbnb,...

Continue Reading
China's Innovative Efforts to Protect Glaciers with Blankets

Updated Category News Views 159

China's Innovative Strategy for Glacier Preservation Recently, China has been making headlines with its unique approach to glacier conservation. This endeavor involves covering glaciers with special 'blankets' designed to protect the ice from rising temperatures and hastening melting due to climate change. Located high above sea level, these efforts are not just...

Continue Reading